ArticleInternational journal of general medicine2025
Dysbiotic Gut Microbiota Correlates with Altered Serum and Urinary Biomarkers in Recurrent Calcium Oxalate Stone Patients.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore associations between gut microbiota composition, blood/urine biochemical markers, and recurrent calcium oxalate stones, identifying potential risk factors. Methods: A retrospective study compared 88 patients (≥2 stone episodes, 2023-2025) with 90 age/gender-matched controls. Fecal 16S rRNA sequencing assessed microbial diversity, alongside blood lipid profiles, creatinine, uric acid, and 24-hour urine analysis. Multivariate logistic regression identified independent predictors. Results: Baseline demographics were comparable (P > 0.05). Patients exhibited higher Escherichia coli and Fusobacterium, lower Faecalibacterium and Lachnospira (P < 0.05). Elevated triglycerides, creatinine, reduced HDL-C, and lower urinary magnesium/citrate (P < 0.05) were observed. Spearman analysis linked E. coli abundance to higher creatinine (r = 0.598) and lower HDL-C (r = -0.607), while Faecalibacterium inversely correlated with creatinine (r = -0.624; all P < 0.05). Logistic regression identified E. coli abundance, serum creatinine, and urinary magnesium as independent recurrence risk factors (P < 0.05). Conclusion: Gut microbiota dysbiosis correlates with metabolic and urinary abnormalities in recurrent stone formers. Monitoring E. coli levels and biochemical parameters may aid recurrence prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.